UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow

Annals of neurology, 2018-11, Vol.84 (5), p.717-728

2018

Volltextzugriff (PDF)

Control of microglial neurotoxicity by the fractalkine receptor

Nature neuroscience, 2006-07, Vol.9 (7), p.917-924

2006

Volltextzugriff (PDF)

Isolation of murine microglial cells for RNA analysis or flow cytometry

Nature protocols, 2006-11, Vol.1 (4), p.1947-1951

2006

Volltextzugriff (PDF)

Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation

EMBO molecular medicine, 2024-09, Vol.16 (9), p.2146-2169

2024

Volltextzugriff (PDF)

Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod

Neurology, 2015-09, Vol.85 (11), p.1001-1003

Huang, DeRen

2015

Volltextzugriff (PDF)

Chemokine Receptor CXCR3: An Unexpected Enigma

Current Topics in Developmental Biology, 2005, Vol.68, p.149-181

2005

Volltextzugriff (PDF)

Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients

Annals of neurology, 2007-07, Vol.62 (1), p.34-39

2007

Volltextzugriff (PDF)

CCL2 recruitment of IL-6-producing CD11b⁺ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity

European journal of immunology, 2008-07, Vol.38 (7), p.1877-1888

2008

Volltextzugriff (PDF)

Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs (P7-3.011)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation

Immunological reviews, 2000-10, Vol.177 (1), p.52-67

2000

Volltextzugriff (PDF)

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial

Circulation (New York, N.Y.), 2015-09, Vol.132 (12), p.1104-1112

2015

Volltextzugriff (PDF)

Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study

JAMA neurology, 2014-09, Vol.71 (9), p.1092

2014

Volltextzugriff (PDF)

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

The New England journal of medicine, 2022-08, Vol.387 (8), p.704-714

2022

Volltextzugriff (PDF)

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

The Lancet (British edition), 2018-03, Vol.391 (10127), p.1263-1273

2018

Volltextzugriff (PDF)

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Lancet neurology, 2018-05, Vol.17 (5), p.405-415

2018

Volltextzugriff (PDF)

Selective Sphingosine-1-Phosphate Receptor 1 Modulation Attenuates Experimental Intracerebral Hemorrhage

Stroke (1970), 2016-07, Vol.47 (7), p.1899-1906

2016

Volltextzugriff (PDF)

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Lancet neurology, 2021-09, Vol.20 (9), p.729-738

2021

Volltextzugriff (PDF)

Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis

Journal of rheumatology, 2002-05, Vol.29 (5), p.950

2002

Volltextzugriff (PDF)

Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis

Journal of leukocyte biology, 2005-02, Vol.77 (2), p.229-237

2005

Volltextzugriff (PDF)

Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene

Journal of rheumatology, 2002-02, Vol.29 (2), p.317

2002

Volltextzugriff (PDF)

Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis

Journal of rheumatology, 2003-07, Vol.30 (7), p.1541

2003

Volltextzugriff (PDF)

Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in Mice

The Journal of neuroscience, 2002-12, Vol.22 (24), p.10633-10642

2002

Volltextzugriff (PDF)

Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies (P6-3.015)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Long-term Follow-up Results from the Phase 2 Multicenter Study of Ublituximab (UTX), a Novel Glycoengineered Anti-CD20 mAb, in Patients with RMS (1167)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis

Central nervous system agents in medicinal chemistry, 2009-03, Vol.9 (1), p.20-31

2009

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Aktive Filter

KollektionSpringer journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(262)

Publikationsform

Sprache

Englisch
(301)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Technology
(126)
Physical Sciences
(114)
Materials Science
(66)
Life Sciences & Biomedicine
(59)
Materials Science, Multidisciplinary
(59)
Physics
(52)
Chemistry
(46)
Physics, Applied
(44)
Humans
(39)
Engineering
(35)
Science & Technology - Other Topics
(32)
Chemistry, Multidisciplinary
(29)
Nanoscience & Nanotechnology
(28)
Engineering, Electrical & Electronic
(26)
Female
(25)
Male
(25)
Remote Sensing
(24)
Silicon
(21)
Chemistry, Physical
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow

Control of microglial neurotoxicity by the fractalkine receptor

Isolation of murine microglial cells for RNA analysis or flow cytometry

Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation

Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod

Chemokine Receptor CXCR3: An Unexpected Enigma

Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients

CCL2 recruitment of IL-6-producing CD11b⁺ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity

Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs (P7-3.011)

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial

Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Selective Sphingosine-1-Phosphate Receptor 1 Modulation Attenuates Experimental Intracerebral Hemorrhage

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis

Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis

Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene

Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis

Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in Mice

Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies (P6-3.015)

Long-term Follow-up Results from the Phase 2 Multicenter Study of Ublituximab (UTX), a Novel Glycoengineered Anti-CD20 mAb, in Patients with RMS (1167)

Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis

Aktive Filter

Suchergebnisse filtern